A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring

Lenvatinib (LENVA) is an oral antineoplastic drug used for the treatment of hepatocellular carcinoma and thyroid carcinoma. LENVA therapeutic drug monitoring (TDM) should be mandatory for a precision medicine to optimize the drug dosage. To this end, the development of a sensitive and robust quantif...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Martina Zanchetta, Valentina Iacuzzi, Bianca Posocco, Giorgia Bortolin, Ariana Soledad Poetto, Marco Orleni, Giovanni Canil, Michela Guardascione, Luisa Foltran, Valentina Fanotto, Fabio Puglisi, Sara Gagno, Giuseppe Toffoli
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/f9a48936ad72401cbcdf79e1c04c6527
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f9a48936ad72401cbcdf79e1c04c6527
record_format	dspace
spelling	oai:doaj.org-article:f9a48936ad72401cbcdf79e1c04c65272021-11-04T06:19:43ZA rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring1932-6203https://doaj.org/article/f9a48936ad72401cbcdf79e1c04c65272021-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547652/?tool=EBIhttps://doaj.org/toc/1932-6203Lenvatinib (LENVA) is an oral antineoplastic drug used for the treatment of hepatocellular carcinoma and thyroid carcinoma. LENVA therapeutic drug monitoring (TDM) should be mandatory for a precision medicine to optimize the drug dosage. To this end, the development of a sensitive and robust quantification method to be applied in the clinical setting is essential. The aim of this work was to develop and validate a sensitive, rapid, and cost-effective LC-MS/MS method for the quantification of LENVA in human plasma. On this premise, sample preparation was based on a protein precipitation and the chromatographic separation was achieved on a Synergi Fusion RP C18 column in 4 min. The method was completely and successfully validated according to European Medicines Agency (EMA) and Food and Drug Administration (FDA) guidelines, with good linearity in the range of 0.50–2000 ng/mL (R≥0.9968). Coefficient of variation (CV) for intra- and inter-day precision was ≤11.3% and accuracy ranged from 96.3 to 109.0%, internal standard normalized matrix effect CV% was ≤2.8% and recovery was ≥95.6%. Successful results were obtained for sensitivity (signal to noise (S/N) ratio >21) and selectivity, dilution integrity (CV% ≤ 4.0% and accuracy 99.9–102%), and analyte stability under various handling and storage conditions both in matrix and solvents. This method was applied to quantify LENVA in patient’s plasma samples and covered the concentration range achievable in patients. In conclusion, a sensitive and robust quantification method was developed and validated to be applied in the clinical setting.Martina ZanchettaValentina IacuzziBianca PosoccoGiorgia BortolinAriana Soledad PoettoMarco OrleniGiovanni CanilMichela GuardascioneLuisa FoltranValentina FanottoFabio PuglisiSara GagnoGiuseppe ToffoliPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Martina Zanchetta Valentina Iacuzzi Bianca Posocco Giorgia Bortolin Ariana Soledad Poetto Marco Orleni Giovanni Canil Michela Guardascione Luisa Foltran Valentina Fanotto Fabio Puglisi Sara Gagno Giuseppe Toffoli A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
description	Lenvatinib (LENVA) is an oral antineoplastic drug used for the treatment of hepatocellular carcinoma and thyroid carcinoma. LENVA therapeutic drug monitoring (TDM) should be mandatory for a precision medicine to optimize the drug dosage. To this end, the development of a sensitive and robust quantification method to be applied in the clinical setting is essential. The aim of this work was to develop and validate a sensitive, rapid, and cost-effective LC-MS/MS method for the quantification of LENVA in human plasma. On this premise, sample preparation was based on a protein precipitation and the chromatographic separation was achieved on a Synergi Fusion RP C18 column in 4 min. The method was completely and successfully validated according to European Medicines Agency (EMA) and Food and Drug Administration (FDA) guidelines, with good linearity in the range of 0.50–2000 ng/mL (R≥0.9968). Coefficient of variation (CV) for intra- and inter-day precision was ≤11.3% and accuracy ranged from 96.3 to 109.0%, internal standard normalized matrix effect CV% was ≤2.8% and recovery was ≥95.6%. Successful results were obtained for sensitivity (signal to noise (S/N) ratio >21) and selectivity, dilution integrity (CV% ≤ 4.0% and accuracy 99.9–102%), and analyte stability under various handling and storage conditions both in matrix and solvents. This method was applied to quantify LENVA in patient’s plasma samples and covered the concentration range achievable in patients. In conclusion, a sensitive and robust quantification method was developed and validated to be applied in the clinical setting.
format	article
author	Martina Zanchetta Valentina Iacuzzi Bianca Posocco Giorgia Bortolin Ariana Soledad Poetto Marco Orleni Giovanni Canil Michela Guardascione Luisa Foltran Valentina Fanotto Fabio Puglisi Sara Gagno Giuseppe Toffoli
author_facet	Martina Zanchetta Valentina Iacuzzi Bianca Posocco Giorgia Bortolin Ariana Soledad Poetto Marco Orleni Giovanni Canil Michela Guardascione Luisa Foltran Valentina Fanotto Fabio Puglisi Sara Gagno Giuseppe Toffoli
author_sort	Martina Zanchetta
title	A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
title_short	A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
title_full	A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
title_fullStr	A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
title_full_unstemmed	A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
title_sort	rapid, simple and sensitive lc-ms/ms method for lenvatinib quantification in human plasma for therapeutic drug monitoring
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/f9a48936ad72401cbcdf79e1c04c6527
work_keys_str_mv	AT martinazanchetta arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT valentinaiacuzzi arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT biancaposocco arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT giorgiabortolin arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT arianasoledadpoetto arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT marcoorleni arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT giovannicanil arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT michelaguardascione arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT luisafoltran arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT valentinafanotto arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT fabiopuglisi arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT saragagno arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT giuseppetoffoli arapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT martinazanchetta rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT valentinaiacuzzi rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT biancaposocco rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT giorgiabortolin rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT arianasoledadpoetto rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT marcoorleni rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT giovannicanil rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT michelaguardascione rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT luisafoltran rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT valentinafanotto rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT fabiopuglisi rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT saragagno rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring AT giuseppetoffoli rapidsimpleandsensitivelcmsmsmethodforlenvatinibquantificationinhumanplasmafortherapeuticdrugmonitoring
_version_	1718445128208613376

A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring

Ejemplares similares